報價延遲最少15分鐘:2025/11/16 02:44 EST
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
12.25 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.02/--
|
|
企業價值
713.68M
|
| 資產負債 |
|
每股賬面淨值
0.07
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/11/16 02:44 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering. |
